Greenway Schond L.
SEC CIK 1848205 · EDGAR
BoughtSold
Most active insiders at DFTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barrow Robert | CEO, Dir | — | $3.08M |
| 2 | Sullivan Mark | CLO | — | $1.04M |
| 3 | Karlin Daniel | Chief Medical Off | — | $748.9K |
| 4 | Roberts Brandi | CFO | — | $135.7K |
| 5 | Wiley Matthew T. | Chief Commercial Off | — | $129.1K |
| 6 | Adsett Roger | Dir | — | — |
| 7 | CRYSTAL ROGER | Dir | — | — |
| 8 | Bruhn Suzanne Louise | Dir | — | — |
| 9 | Krebs Andreas | Dir | — | — |
| 10 | Vallone Carol A | Dir | — | — |
Greenway Schond L. made no open-market trades at DFTX in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-26 | 2024-03-25 | DFTX | Definium Therapeutics, Inc. | Greenway Schond L. | CFO | F - Tax | $9.78 | -5,560 | 211.1K | -3% | -$54.4K | |
| 2023-12-26 | 2023-12-26 | DFTX | Definium Therapeutics, Inc. | Greenway Schond L. | CFO | S - Sale | $3.63 | -5,652 | 216.6K | -3% | -$20.5K | |
| M | 2023-09-25 | 2023-09-25 | DFTX | Definium Therapeutics, Inc. | Greenway Schond L. | CFO | S - Sale | $3.58 | -5,762 | 226.1K | -2% | -$20.6K |
| 2023-08-28 | 2023-08-25 | DFTX | Definium Therapeutics, Inc. | Greenway Schond L. | CFO | S - Sale | $3.80 | -20.0K | 228.0K | -8% | -$76.0K | |
| M | 2023-06-27 | 2023-06-27 | DFTX | Definium Therapeutics, Inc. | Greenway Schond L. | CFO | S - Sale | $3.20 | -11.6K | 248.0K | -4% | -$37.2K |
| A | 2023-04-24 | 2023-03-14 | DFTX | Definium Therapeutics, Inc. | Greenway Schond L. | CFO | A - Grant | $0.00 | +175.0K | 259.7K | +207% | $0 |
| 2023-03-17 | 2023-03-14 | DFTX | Definium Therapeutics, Inc. | Greenway Schond L. | CFO | A - Grant | $0.00 | +175.0K | 1.45M | +14% | $0 | |
| DA | 2022-06-03 | 2022-05-23 | DFTX | Definium Therapeutics, Inc. | Greenway Schond L. | CFO | A - Grant | $0.00 | +1.27M | 1.27M | New | $0 |
| D | 2022-05-23 | 2022-05-23 | DFTX | Definium Therapeutics, Inc. | Greenway Schond L. | CFO | A - Grant | $0.00 | +1.27M | 1.27M | New | $0 |
| 2021-12-14 | 2021-12-10 | AVTX | Avalo Therapeutics, Inc. | Greenway Schond L. | CFO | P - Purchase | $1.57 | +2,231 | 3,883 | +135% | +$3,503 |
Purchase Sale Sale after option exercise All abbreviations